Postmarketing Surveillance Study for Kyprolis® (carfilzomib) in Korea (20160117)

30/06/2017
27/03/2024
EU PAS number:
EUPAS18108
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

01 20 01 Protocol Ver 1 0 2016-03-29 English (002)

English (717.33 KB - PDF) View document
Study results
Study results

20160117 abstract ORSR_Redacted

English (172.51 KB - PDF) View document
Study report
Other information